Patent ID: 6130208
Filing Date: 2000-10-10
Classification: A61P,C07H

Abstract:
A pharmaceutical composition comprising a nucleotide analog and one or more glass forming additives, wherein the nucleotide is a compound of formula (I): ##STR6## wherein R.sup.1 and R.sup.2 independently represent hydrogen or halogen, R.sup.3 and R.sup.4 independently represent phenyl, or C.sub.1-6 -alkyl optionally substituted by one or more substituents selected from OR.sup.5, C.sub.1-6 -alkylthio, NR.sup.6 R.sup.7, phenyl, COOR.sup.8 and halogen,R.sup.5, R.sup.6, R.sup.7 and R.sup.8 independent represent hydrogen or C.sub.1-6 -alkyl and X represents an acidic moiety, or a pharmaceutically acceptable salt thereof.